CIRFF, Center of Drug Utilization and Pharmacoeconomics, University of Naples Federico II, Naples, Italy.
Department of Pharmacy, University of Naples Federico II, Naples, Italy.
PLoS One. 2021 Jan 20;16(1):e0237202. doi: 10.1371/journal.pone.0237202. eCollection 2021.
The novel coronavirus (SARS-CoV-2) pandemic spread rapidly worldwide increasing exponentially in Italy. To date, there is lack of studies describing clinical characteristics of the people at high risk of infection. Hence, we aimed (i) to identify clinical predictors of SARS-CoV-2 infection risk, (ii) to develop and validate a score predicting SARS-CoV-2 infection risk, and (iii) to compare it with unspecific scores.
Retrospective case-control study using administrative health-related database was carried out in Southern Italy (Campania region) among beneficiaries of Regional Health Service aged over than 30 years. For each person with SARS-CoV-2 confirmed infection (case), up to five controls were randomly matched for gender, age and municipality of residence. Odds ratios and 90% confidence intervals for associations between candidate predictors and risk of infection were estimated by means of conditional logistic regression. SARS-CoV-2 Infection Score (SIS) was developed by generating a total aggregate score obtained from assignment of a weight at each selected covariate using coefficients estimated from the model. Finally, the score was categorized by assigning increasing values from 1 to 4. Discriminant power was used to compare SIS performance with that of other comorbidity scores.
Subjects suffering from diabetes, anaemias, Parkinson's disease, mental disorders, cardiovascular and inflammatory bowel and kidney diseases showed increased risk of SARS-CoV-2 infection. Similar estimates were recorded for men and women and younger and older than 65 years. Fifteen conditions significantly contributed to the SIS. As SIS value increases, risk progressively increases, being odds of SARS-CoV-2 infection among people with the highest SIS value (SIS = 4) 1.74 times higher than those unaffected by any SIS contributing conditions (SIS = 1).
Conditions and diseases making people more vulnerable to SARS-CoV-2 infection were identified by the current study. Our results support decision-makers in identifying high-risk people and adopting of preventive measures to minimize the spread of further epidemic waves.
新型冠状病毒(SARS-CoV-2)在全球范围内迅速传播,在意大利呈指数级增长。迄今为止,缺乏描述感染高风险人群临床特征的研究。因此,我们的目的是:(i)确定 SARS-CoV-2 感染风险的临床预测因素;(ii)开发和验证预测 SARS-CoV-2 感染风险的评分系统;(iii)并将其与非特异性评分系统进行比较。
我们在意大利南部(坎帕尼亚地区)进行了一项回顾性病例对照研究,研究对象为区域卫生服务的受益者,年龄均在 30 岁以上。对于每例确诊的 SARS-CoV-2 感染患者(病例),我们按性别、年龄和居住地的市镇随机匹配了 5 名对照。采用条件逻辑回归估计候选预测因素与感染风险之间的关联的比值比及其 90%置信区间。通过为每个选定的协变量分配权重,利用模型中估计的系数,生成一个总综合评分,从而制定 SARS-CoV-2 感染评分(SIS)。最后,将评分分为 1-4 级,分值递增。通过比较 SIS 与其他合并症评分的判别能力来评估 SIS 的性能。
患有糖尿病、贫血、帕金森病、精神障碍、心血管疾病、炎症性肠病和肾病的患者,SARS-CoV-2 感染的风险增加。男性和女性以及 65 岁以上和以下的人群都有类似的估计值。15 种疾病显著影响 SIS。随着 SIS 值的增加,风险逐渐增加,SIS 值最高(SIS=4)的人群感染 SARS-CoV-2 的几率是不受任何 SIS 相关因素影响的人群(SIS=1)的 1.74 倍。
本研究确定了使人们更容易感染 SARS-CoV-2 的条件和疾病。我们的研究结果为决策者识别高风险人群提供了支持,并采取预防措施以最大限度地减少进一步疫情的传播。